These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 1598117

  • 1. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM, Pasternak RC, Weinstein MC, Friesinger GC, Ridker PM, Tosteson AN, Goldman L.
    N Engl J Med; 1992 Jul 02; 327(1):7-13. PubMed ID: 1598117
    [Abstract] [Full Text] [Related]

  • 2. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB, Hlatky MA, Califf RM, Naylor CD, Lee KL, Armstrong PW, Barbash G, White H, Simoons ML, Nelson CL.
    N Engl J Med; 1995 May 25; 332(21):1418-24. PubMed ID: 7723799
    [Abstract] [Full Text] [Related]

  • 3. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
    Kent DM, Vijan S, Hayward RA, Griffith JL, Beshansky JR, Selker HP.
    J Clin Epidemiol; 2004 Aug 25; 57(8):843-52. PubMed ID: 15485737
    [Abstract] [Full Text] [Related]

  • 4. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.
    Newby LK, Eisenstein EL, Califf RM, Thompson TD, Nelson CL, Peterson ED, Armstrong PW, Van de Werf F, White HD, Topol EJ, Mark DB.
    N Engl J Med; 2000 Mar 16; 342(11):749-55. PubMed ID: 10717009
    [Abstract] [Full Text] [Related]

  • 5. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP, Franzosi MG, Santoro E, White H, Van de Werf F, Tognoni G.
    N Engl J Med; 1992 Jul 02; 327(1):1-6. PubMed ID: 1598096
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of the cost effectiveness of treatment of acute myocardial infarct with primary angioplasty and thrombolysis ].
    Golán L, Simek S, Linhart A, Cahlík T, Palecek T, Lubanda JC, Korínek J, Beran S, Aschermann M.
    Vnitr Lek; 2003 Feb 02; 49(2):97-102. PubMed ID: 12728575
    [Abstract] [Full Text] [Related]

  • 7. Management of myocardial infarction in the elderly: admission and outcome on a coronary care unit.
    Haigh R, Castleden M, Woods K, Fletcher S, Bowns I, Gibson M, Soper J.
    Health Trends; 2003 Feb 02; 23(4):154-7. PubMed ID: 10117736
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of captopril therapy after myocardial infarction.
    Tsevat J, Duke D, Goldman L, Pfeffer MA, Lamas GA, Soukup JR, Kuntz KM, Lee TH.
    J Am Coll Cardiol; 1995 Oct 02; 26(4):914-9. PubMed ID: 7560617
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of the cost-effectiveness of thrombolytic therapy in acute myocardial infarct using tissue plasminogen activator or streptokinase:the Italian perspective].
    Lorenzoni R, Fattore G, Gensini G.
    G Ital Cardiol; 1997 Jul 02; 27(7):721-6. PubMed ID: 9303862
    [Abstract] [Full Text] [Related]

  • 10. Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction.
    Goel V, Naylor CD.
    Can J Cardiol; 1992 Jul 02; 8(1):31-8. PubMed ID: 1617509
    [Abstract] [Full Text] [Related]

  • 11. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.
    Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, van 't Hof AW, Suryapranata H.
    N Engl J Med; 1999 Nov 04; 341(19):1413-9. PubMed ID: 10547403
    [Abstract] [Full Text] [Related]

  • 12. Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria.
    Lee YY, Tee MH, Zurkurnai Y, Than W, Sapawi M, Suhairi I.
    Singapore Med J; 2008 Apr 04; 49(4):304-10. PubMed ID: 18418522
    [Abstract] [Full Text] [Related]

  • 13. Potential cost effectiveness of tissue plasminogen activator among patients previously treated with streptokinase.
    Massel D.
    Can J Cardiol; 1999 Feb 04; 15(2):173-9. PubMed ID: 10079776
    [Abstract] [Full Text] [Related]

  • 14. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2).
    Maggioni AP, Maseri A, Fresco C, Franzosi MG, Mauri F, Santoro E, Tognoni G.
    N Engl J Med; 1993 Nov 11; 329(20):1442-8. PubMed ID: 8413454
    [Abstract] [Full Text] [Related]

  • 15. TERIMA-2: national extension of thrombolytic treatment with recombinant streptokinase in acute myocardial infarct in Cuba.
    TERIMA Group of Investigators.
    Thromb Haemost; 2000 Dec 11; 84(6):949-54. PubMed ID: 11330244
    [Abstract] [Full Text] [Related]

  • 16. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study.
    Chandra H, Yarzebski J, Goldberg RJ, Savageau J, Singleton C, Gurwitz JH, Gore JM.
    Arch Intern Med; 1997 Apr 14; 157(7):741-6. PubMed ID: 9125005
    [Abstract] [Full Text] [Related]

  • 17. Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study.
    Marcoff L, Zhang Z, Zhang W, Ewen E, Jurkovitz C, Leguet P, Kolm P, Weintraub WS.
    J Am Coll Cardiol; 2009 Sep 29; 54(14):1271-9. PubMed ID: 19778669
    [Abstract] [Full Text] [Related]

  • 18. [Are ECG criteria for indications for thrombolysis in acute myocardial infarct defined too narrowly?].
    Weiss P, Sarasin C, Ritz R, Pfisterer M.
    Schweiz Med Wochenschr; 1991 Dec 07; 121(49):1829-32. PubMed ID: 1754866
    [Abstract] [Full Text] [Related]

  • 19. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W, Pierre K, Massel D.
    Can J Cardiol; 2005 Apr 07; 21(5):423-31. PubMed ID: 15861260
    [Abstract] [Full Text] [Related]

  • 20. Quality of life of elderly patients after prehospital thrombolytic therapy.
    Väisänen O, Mäkijärvi M, Silfvast T.
    Resuscitation; 2005 Aug 07; 66(2):183-8. PubMed ID: 15955612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.